Shares of the health care conglomerate dropped after the sudden departure of Karen Lynch and a downbeat update on the state ...

CVS Health replaced its top executive as it warned that its coming earnings will once again fall short of Wall Street ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for current CEO Karen ...

Shares are down by nearly half from their 2022 highs, in part due to repeated profit forecast cuts related to rising costs in ...

CVS Health CEO Karen Lynch has stepped down with company shares sinking 19% this year and the health care giant struggling on ...

CVS Health Corp. named David Joyner as its new chief executive officer, ending a tumultuous tenure for Karen Lynch at the ...

CVS Health stock sold for $72.08 a share when Karen Lynch became president and CEO in 2021. It closed at $60.35 on Friday.

CVS has been struggling with rising medical costs in its Medicare Advantage plans and slumping drugstore sales.

America’s largest drug store chain named a new chief executive officer on Friday, with longtime CVS Health executive David ...

CVS Health's turnaround could be long and difficult amid CEO change, rising costs, and potential divestitures, while ...

CVS Health has a new CEO: David Joyner, a seasoned veteran in the healthcare industry, is stepping into the challenging role.

CVS Health Chief Executive Officer Karen Lynch has stepped down and will be replaced by David Joyner, who runs the company's ...